File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.arr.2021.101464
- Scopus: eid_2-s2.0-85115920749
- WOS: WOS:000706991500007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Autophagy in Alzheimer’s disease pathogenesis: Therapeutic potential and future perspectives
Title | Autophagy in Alzheimer’s disease pathogenesis: Therapeutic potential and future perspectives |
---|---|
Authors | |
Issue Date | 1-Dec-2021 |
Publisher | Elsevier |
Citation | Ageing Research Reviews, 2021, v. 72 How to Cite? |
Abstract | Alzheimer's disease (AD) is a complex neurodegenerative disease in the elderly and the most common cause of human dementia. AD is characterized by accumulation of abnormal protein aggregates including amyloid plaques (composed of beta-amyloid (A beta) peptides) and neurofibrillary tangles (formed by hyper-phosphorylated tau protein). Synaptic plasticity, neuroinflammation, calcium signaling etc. also show dysfunction in AD patients. Autophagy is an evolutionarily conserved lysosome-dependent cellular event in eukaryotes. It is closely linked to modulation of protein metabolism, through which damaged organelles and mis-folded proteins are degraded and then recycled to maintain protein homeostasis. Accumulating evidence has shown that impaired autophagy also contributes to AD pathogenesis. In the present review, we highlight the role of autophagy, including bulk and selective autophagy, in regulating metabolic circuits in AD pathogenesis. We also discuss the potential and future perspectives of autophagy-inducing strategies in AD therapeutics. |
Persistent Identifier | http://hdl.handle.net/10722/339692 |
ISSN | 2023 Impact Factor: 12.5 2023 SCImago Journal Rankings: 3.376 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zhang, Zhigang | - |
dc.contributor.author | Yang, Xifei | - |
dc.contributor.author | Song, You-Qiang | - |
dc.contributor.author | Tu, Jie | - |
dc.date.accessioned | 2024-03-11T10:38:37Z | - |
dc.date.available | 2024-03-11T10:38:37Z | - |
dc.date.issued | 2021-12-01 | - |
dc.identifier.citation | Ageing Research Reviews, 2021, v. 72 | - |
dc.identifier.issn | 1568-1637 | - |
dc.identifier.uri | http://hdl.handle.net/10722/339692 | - |
dc.description.abstract | <p>Alzheimer's disease (AD) is a complex neurodegenerative disease in the elderly and the most common cause of human dementia. AD is characterized by accumulation of abnormal protein aggregates including amyloid plaques (composed of beta-amyloid (A beta) peptides) and neurofibrillary tangles (formed by hyper-phosphorylated tau protein). Synaptic plasticity, neuroinflammation, calcium signaling etc. also show dysfunction in AD patients. Autophagy is an evolutionarily conserved lysosome-dependent cellular event in eukaryotes. It is closely linked to modulation of protein metabolism, through which damaged organelles and mis-folded proteins are degraded and then recycled to maintain protein homeostasis. Accumulating evidence has shown that impaired autophagy also contributes to AD pathogenesis. In the present review, we highlight the role of autophagy, including bulk and selective autophagy, in regulating metabolic circuits in AD pathogenesis. We also discuss the potential and future perspectives of autophagy-inducing strategies in AD therapeutics.<br></p> | - |
dc.language | eng | - |
dc.publisher | Elsevier | - |
dc.relation.ispartof | Ageing Research Reviews | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.title | Autophagy in Alzheimer’s disease pathogenesis: Therapeutic potential and future perspectives | - |
dc.type | Article | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1016/j.arr.2021.101464 | - |
dc.identifier.scopus | eid_2-s2.0-85115920749 | - |
dc.identifier.volume | 72 | - |
dc.identifier.eissn | 1872-9649 | - |
dc.identifier.isi | WOS:000706991500007 | - |
dc.identifier.issnl | 1568-1637 | - |